Literature DB >> 14679060

Establishing insulin 1 and insulin 2 knockout congenic strains on NOD genetic background.

Johanna Paronen1, Hiroaki Moriyama, Norio Abiru, Kamila Sikora, Evie Melanitou, Sunanda Babu, Fei Bao, Edwin Liu, Dongmei Miao, George S Eisenbarth.   

Abstract

As insulin is a major autoantigen in autoimmune diabetes and because the insulin gene region locus in humans has been linked to diabetes risk, we have bred insulin gene knockouts onto the NOD mouse. Mice differ from humans in terms that they express two nonallelic genes of insulin. Insulin 2 is the murine homologue of the human insulin gene and is located on mouse chromosome 7. Insulin 1 is thought to have evolved by a gene duplication event, lacks the second intron of the insulin 2 gene, and is located on mouse chromosome 19. The differential thymic expression of the insulin gene may be important for central tolerance induction. Here, we present the initial establishment of congenic knockouts and characterization of the congenic intervals corresponding to insulin 1 and insulin 2 knockout genes on mouse chromosome 19 and 7, respectively.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14679060     DOI: 10.1196/annals.1288.027

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  2 in total

1.  Evidence for a primary islet autoantigen (preproinsulin 1) for insulitis and diabetes in the nonobese diabetic mouse.

Authors:  Hiroaki Moriyama; Norio Abiru; Johanna Paronen; Kamila Sikora; Edwin Liu; Dongmei Miao; Devasenan Devendra; Joshua Beilke; Roberto Gianani; Ron G Gill; George S Eisenbarth
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-18       Impact factor: 11.205

2.  C-Abl inhibitor imatinib enhances insulin production by β cells: c-Abl negatively regulates insulin production via interfering with the expression of NKx2.2 and GLUT-2.

Authors:  Chang-Qing Xia; Pengcheng Zhang; Shiwu Li; Lihui Yuan; Tina Xia; Chao Xie; Michael J Clare-Salzler
Journal:  PLoS One       Date:  2014-05-16       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.